Related Experiment Video
Updated: Jul 20, 2026

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
Published on: May 16, 2021
Acute bacterial endocarditis. Optimizing surgical results
R I Larbalestier1, N M Kinchla, S F Aranki
1Department of Surgery, Harvard Medical School, Boston, MA.
Surgical intervention for acute bacterial endocarditis is crucial for high-risk patients. Early aggressive surgery improves outcomes, especially for prosthetic valve endocarditis (PVE) and non-streptococcal infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Intervention
Background:
- Acute bacterial endocarditis presents significant morbidity.
- While antibiotics are common, a subset of patients requires surgical intervention.
Purpose of the Study:
- To analyze outcomes of surgical treatment for acute bacterial endocarditis.
- To identify factors influencing morbidity and mortality in these patients.
Main Methods:
- Retrospective review of 158 patients undergoing heart valve surgery for acute bacterial endocarditis (1972-1991).
- Analysis included native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE) subgroups.
- Outcomes assessed included operative mortality, long-term survival, and recurrent endocarditis rates.
Main Results:
- Operative mortality was 6% for NVE and 22% for PVE.
- Ten-year survival was 66% for NVE and 29% for PVE.
- Prosthetic valve endocarditis and non-streptococcal infections were associated with decreased survival.
Conclusions:
- Surgical outcomes for acute endocarditis are influenced by infection site, severity, and patient factors.
- Early, aggressive surgical intervention is recommended to optimize results.
- Particular attention should be given to patients with non-streptococcal infection or PVE.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management

